Want to see KRSA full AI Analyst Report?
Korsana Biosciences (KRSA) Financial Statements
Korsana Biosciences Financial Overview
Korsana Biosciences's market cap is currently $1.37B. The company's EPS TTM is $-12.04; its P/E ratio is -2.50; Korsana Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.07M | $ 2.00M | $ 0.00 | $ 297.00K | $ 3.32M |
| Gross Profit | $ 2.07M | $ 2.00M | $ -1.31M | $ -5.28M | $ 3.32M |
| Operating Income | $ -4.97M | $ -3.63M | $ -12.95M | $ -18.54M | $ -55.20M |
| EBITDA | $ -3.53M | $ -3.06M | $ -9.58M | $ -18.18M | $ -53.84M |
| Net Income | $ -3.53M | $ -3.06M | $ -5.26M | $ -44.08M | $ -51.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.24M | $ 3.23M | $ 7.57M | $ 13.38M | $ 53.96M |
| Total Assets | $ 9.98M | $ 9.57M | $ 13.37M | $ 18.08M | $ 59.33M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -3.24M | $ -3.23M | $ -7.57M | $ -13.38M | $ -53.96M |
| Total Liabilities | $ 900.00K | $ 725.00K | $ 2.09M | $ 7.63M | $ 11.09M |
| Stockholders' Equity | $ 9.09M | $ 8.85M | $ 11.29M | $ 10.45M | $ 48.25M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.31M | $ -4.33M | $ -21.25M | $ -40.61M | $ -36.52M |
| Operating Cash Flow | $ -3.31M | $ -4.33M | $ -21.25M | $ -40.61M | $ -36.52M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 10.40M | $ 0.00 | $ 1.46M |
| Financing Cash Flow | $ 3.32M | $ 0.00 | $ 5.02M | $ 29.00K | $ 30.79M |
Currency in USD